Evaluation of Microsphere-based xMAP Test for gyrA Mutation Identification in Mycobacterium Tuberculosis
作者机构:National Center for Tuberculosis Control and PreventionChinese Center for Disease Control and PreventionBeijing 102206China School of Public HealthPeking UniversityBeijing 100191China
出 版 物:《Biomedical and Environmental Sciences》 (生物医学与环境科学(英文版))
年 卷 期:2023年第36卷第4期
页 面:384-387页
核心收录:
学科分类:0830[工学-环境科学与工程(可授工学、理学、农学学位)] 1004[医学-公共卫生与预防医学(可授医学、理学学位)] 1001[医学-基础医学(可授医学、理学学位)] 100103[医学-病原生物学] 10[医学]
基 金:funded by the National Key R&D Program [2022YFC2305200] China CDC-Tuberculosis Control and Prevention Project 。
主 题:tuberculosis drugs Mycobacterium
摘 要:Drug-resistant(DR) tuberculosis(TB) is a growing threat to public health[1]. Fluoroquinolone(FQ) antibiotics have long been used as anti-tuberculosis drugs, and their widespread application has led to the development of resistance in clinical isolates of Mycobacterium tuberculosis complex(MTBC).